ReviewInternal medicine (Tokyo, Japan)2025

Successful Switch to Afatinib and Osimertinib Rechallenge with Corticosteroids after Osimertinib-induced Interstitial Lung Disease: A Case Report and Literature Review.

Masaaki Yanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.